A detailed history of Rhumbline Advisers transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Rhumbline Advisers holds 10,086 shares of AMRN stock, worth $4,437. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,086
Previous 7,546 33.66%
Holding current value
$4,437
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$0.57 - $0.8 $1,447 - $2,032
2,540 Added 33.66%
10,086 $6,000
Q2 2024

Aug 01, 2024

SELL
$0.63 - $1.07 $231 - $393
-368 Reduced 4.65%
7,546 $5,000
Q1 2024

May 09, 2024

BUY
$0.82 - $1.35 $3,096 - $5,097
3,776 Added 91.25%
7,914 $7,000
Q4 2023

Feb 08, 2024

BUY
$0.66 - $0.91 $1,671 - $2,305
2,533 Added 157.82%
4,138 $3,000
Q3 2023

Nov 09, 2023

BUY
$0.85 - $1.43 $174 - $293
205 Added 14.64%
1,605 $1,000
Q2 2023

Aug 08, 2023

BUY
$1.12 - $1.49 $1,568 - $2,086
1,400 New
1,400 $1,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.